Financial statements Hemolens Diagnostics
Balance sheet of Hemolens Diagnostics
Company age:
Age:
9 y. 10 m. 16 d.
Share capital:
Share capital:
25 650 PLN
Balance sheet data of HEMOLENS DIAGNOSTICS
|
Year
|
2018
|
2019
|
2020
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 3 950 065,52 | 6 748 372,27 | 2 609 614,62 | 42 333 034,47 | 69 578 345,73 |
| A. Fixed assets | 92 776,15 | 104 591,26 | 473 849,33 | 36 192 940,94 | 58 572 707,48 |
| B. Current assets | 3 856 889,37 | 6 643 781,01 | 2 135 765,29 | 6 140 093,53 | 11 005 638,25 |
| C. Share capital contributions (basic funds) | 400,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 3 950 065,52 | 6 748 372,27 | 2 609 614,62 | 42 333 034,47 | 69 578 345,73 |
| A. Equity | 3 447 250,12 | 5 964 900,26 | 1 244 350,92 | 30 761 840,95 | 54 639 809,53 |
| B. Liabilities and provisions for liabilities | 502 815,40 | 783 472,01 | 1 365 263,70 | 11 571 193,52 | 14 938 536,20 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 501 315,40 | 781 972,01 | 1 165 263,70 | 4 021 950,31 | 4 346 471,91 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.